Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey

Background and aims We used data from the Continuing to Confront COPD International Patient Survey to test the hypothesis that patients with COPD who report less engagement with their disease management are also more likely to report greater impact of the disease. Methods This was a population-based, cross-sectional survey of 4,343 subjects aged ≥40 years from 12 countries, fulfilling a case definition of COPD based on self-reported physician diagnosis or symptomatology. The impact of COPD was measured with COPD Assessment Test, modified Medical Research Council Dyspnea Scale, and hospital admissions and emergency department visits for COPD in the prior year. The 13-item Patient Activation Measure (PAM-13) instrument and the 8-item Morisky Medication Adherence Scale (MMAS-8) were used to measure patient disease engagement and medication adherence, respectively. Results Twenty-eight percent of subjects reported being either disengaged or struggling with their disease (low engagement: PAM-13 levels 1 and 2), and 35% reported poor adherence (MMAS-8 <6). In univariate analyses, lower PAM-13 and MMAS-8 scores were significantly associated with poorer COPD-specific health status, greater breathlessness and lower BMI (PAM-13 only), less satisfaction with their doctor’s management of COPD, and more emergency department visits. In multivariate regression models, poor satisfaction with their doctor’s management of COPD was significantly associated with both low PAM-13 and MMAS-8 scores; low PAM-13 scores were additionally independently associated with higher COPD Assessment Test and modified Medical Research Council scores and low BMI (underweight). Conclusion Poor patient engagement and medication adherence are frequent and associated with worse COPD-specific health status, higher health care utilization, and lower satisfaction with health care providers. More research will be needed to better understand what factors can be modified to improve medication adherence and patient engagement.

[1]  M Cazzola,et al.  Symptom variability in patients with severe COPD: a pan-European cross-sectional study , 2010, European Respiratory Journal.

[2]  W. Lynch,et al.  The association of smoking with medical treatment adherence in the workforce of a large employer , 2014, Patient preference and adherence.

[3]  H. Ward,et al.  Predictive Validity of a Medication Adherence Measure in an Outpatient Setting , 2008, Journal of clinical hypertension.

[4]  Jacqueline A Pugh,et al.  Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. , 2007, Archives of internal medicine.

[5]  D. Mannino,et al.  Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. , 2013, Chest.

[6]  M. Dimatteo,et al.  Improving the measurement of self-reported medication nonadherence: Final response , 2011 .

[7]  Chad Boult,et al.  Psychometric properties of the patient activation measure among multimorbid older adults. , 2011, Health services research.

[8]  Jonathan N. Hawley,et al.  Patient Activation Is Associated With Healthy Behaviors and Ease in Managing Diabetes in an Indigent Population , 2009, The Diabetes educator.

[9]  Hao Li,et al.  Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care , 2014, PloS one.

[10]  Richard Baker,et al.  Older people's preferences for involvement in their own care: a qualitative study in primary health care in 11 European countries. , 2007, Patient education and counseling.

[11]  A. Turner,et al.  Evaluation of a self-management programme for patients with chronic obstructive pulmonary disease , 2014, Chronic respiratory disease.

[12]  Glyn Elwyn,et al.  Consumers’ views of quality in the consultation and their relevance to ‘shared decision‐making’ approaches , 2001, Health expectations : an international journal of public participation in health care and health policy.

[13]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[14]  P. J. Barnes,et al.  Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.

[15]  Pamala A. Pawloski,et al.  Patient Characteristics Associated with Medication Adherence , 2013, Clinical Medicine & Research.

[16]  Len Fromer,et al.  Implementing chronic care for COPD: planned visits, care coordination, and patient empowerment for improved outcomes , 2011, International journal of chronic obstructive pulmonary disease.

[17]  L. Ring,et al.  Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions , 2007, Pharmacoepidemiology and drug safety.

[18]  N. Anthonisen,et al.  Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. , 1995, Chest.

[19]  Michelle P. Salyers,et al.  Levels of Patient Activation Among Adults With Schizophrenia: Associations With Hope, Symptoms, Medication Adherence, and Recovery Attitudes , 2013, The Journal of nervous and mental disease.

[20]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[21]  Judith H Hibbard,et al.  Development and testing of a short form of the patient activation measure. , 2005, Health services research.

[22]  G. Cochrane,et al.  Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. , 1997, Chest.

[23]  J. Bourbeau,et al.  Patient adherence in COPD , 2008, Thorax.

[24]  F. Snoek Breaking the barriers to optimal glycaemic control--what physicians need to know from patients' perspectives. , 2002, International journal of clinical practice. Supplement.

[25]  J. McElnay,et al.  Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD) , 2012, European Journal of Clinical Pharmacology.

[26]  D. Mannino,et al.  Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013 , 2014, International journal of chronic obstructive pulmonary disease.

[27]  Marie Krousel-Wood,et al.  New medication adherence scale versus pharmacy fill rates in seniors with hypertension. , 2009, The American journal of managed care.

[28]  M. Hendriks,et al.  Relationships between patient activation, disease-specific knowledge and health outcomes among people with diabetes; a survey study , 2014, BMC Health Services Research.

[29]  Judith H Hibbard,et al.  How engaged are consumers in their health and health care, and why does it matter? , 2008, Research brief.

[30]  N. Zhong,et al.  Non‐smoking‐related chronic obstructive pulmonary disease: A neglected entity? , 2012, Respirology.

[31]  J. Hibbard,et al.  How well do patient activation scores predict depression outcomes one year later? , 2014, Journal of Affective Disorders.

[32]  Adam T. Perzynski,et al.  Effectiveness and Safety of Patient Activation Interventions for Adults with Type 2 Diabetes: Systematic Review, Meta-Analysis, and Meta-regression , 2014, Journal of General Internal Medicine.

[33]  J. George,et al.  Factors associated with medication nonadherence in patients with COPD: Chest 2005;128:3198–204 , 2006 .

[34]  J. Cramer,et al.  Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. , 2007, Canadian respiratory journal.

[35]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[36]  Á. Mészáros,et al.  Factors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease , 2011, Respiration.

[37]  Min Xi,et al.  Patient Perception , Preference and Participation Measuring self-management of patients ’ and employees ’ health : Further validation of the Patient Activation Measure ( PAM ) based on its relation to employee characteristics § , 2009 .

[38]  J A Anderson,et al.  Adherence to inhaled therapy, mortality and hospital admission in COPD , 2009, Thorax.

[39]  Anand A. Dalal,et al.  Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. , 2012, The American journal of geriatric pharmacotherapy.